This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 05/23/2023
Location: Virtual
Subject: Real: Health Equity Summit 2023; Foot on the Gas: Action, Accountability and Acceleration
FDA Participant/Group: NAMANDJE BUMPUS;
Non FDA Participant/Group: Government, industry, media, academia, and other registered attendees

Event Date: 05/23/2023
Location: Silver Spring, MD
Subject: Food and Drug Administration Alumni Association Spring Fling
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Food and Drug Administration Alumni Association

Event Date: 05/23/2023
Location: Baltimore, MD
Subject: Society of Clinical Trials 2023: Academic Led Trials for Regulatory Use
FDA Participant/Group: N/A
Non FDA Participant/Group: Academic, industry, and other registered attendees

Event Date: 05/24/2023
Location: Washington, DC
Subject: Reagan-Udall Foundation for the FDA Annual Public Meeting and Board Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Event Date: 05/24/2023
Location: Oxon Hill, MD
Subject: World Orphan Drug Congress USA
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Event Date: 05/25/2023
Location: Washington, DC
Subject: Nobel Prize Summit on Truth, Trust, and Hope
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Event Date: 05/25/2023
Location: Washington, DC
Subject: The Mercury Project Cocktail Reception
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, and other registered attendees

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 05/22/2023
Location: Virtual
Subject: Generic Drug Supply Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the Association of Accessible Medicines

Event Date: 05/23/2023
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Kuldev Singh (Stanford Health Care);

Event Date: 05/24/2023
Location: Virtual
Subject: CDER / CBER Priorities and FDA / Industry Opportunities for Collaboration
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of Pharmaceutical Research and Manufacturers of America (PhRMA)

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/22/2023
Location: Washington, DC
Subject: Friends of Cancer Research; The Next Generation of Cellular Therapies: A Blueprint to Accelerate Development; Panelist: The Next Horizon for Cancer Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, patient stakeholders

Event Date: 05/23/2023
Location: Virtual
Subject: Actions to Advance the Development of Gene Therapy for Rare Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Research!America Alliance

Event Date: 05/24/2023
Location: National Harbor, MD
Subject: World Orphan Drug Congress USA 2023; Panelist: Expediting Drug Development for Rare Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, and patient advocate stakeholders

Event Date: 05/25/2023
Location: Virtual
Subject: Association for the Advancement of Blood and Biotherapies Hot Topic Discussion; Individual Donor Risk Assessment Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, healthcare, and academia stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 05/24/2023
Location: Silver Spring, MD
Subject: General Medical Devices
FDA Participant/Group: JULIANE LESSARD; JESSICA PAULSEN; DAVID WOLLOSCHECK; SONJA FULMER; COURTNEY LIAS; WILLIAM MAISEL; TROY TAZBAZ;
Non FDA Participant/Group: Adam Vasquez, Bakul Patel, Sr., Jonelle Saunders, Sam Sheng, Shakil Barkat (Google); Vernessa Pollard (McDermott Will & Emery LLP);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 05/23/2023
Location: Virtual
Subject: FDA's Nutrition Priorities
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Shiriki Kumanyika (Drexel University, Dornsife, School of Public Health);

Event Date: 05/23/2023
Location: Virtual
Subject: FDA's Nutrition Priorities
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Leslie Sarasin (Food Marketing Institute);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 05/21/2023
Location: Washington, DC
Subject: Behavioral Science and Health Services Research
FDA Participant/Group: N/A
Non FDA Participant/Group: Several attendees from the American Thoracic Society Assembly

Event Date: 05/21/2023
Location: Washington, DC
Subject: Assisting FDA’s Tobacco Regulatory Efforts
FDA Participant/Group: N/A
Non FDA Participant/Group: Several attendees from the American Thoracic Society Tobacco Action Committee.

Event Date: 05/22/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Cristine Delnevo (Rutgers University);

Event Date: 05/22/2023
Location: Washington, DC
Subject: CTP’s Current Regulatory and Enforcement Efforts
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members and staff from the U.S. House Committee on Oversight

Event Date: 05/23/2023
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from ICF International, Inc

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event